Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 4, 2002, Pages 1051-1057

  Nishioka, Takeshi ^a   Shiga, Tohru ^a   Shirato, Hiroki ^a   Tsukamoto, Eriko ^a   Tsuchiya M d, Kazuhiko ^a   Kato, Takashi ^a   Ohmori, Keiichi ^b   Yamazaki, Akira ^a   Aoyama, Hidefumi ^a   Hashimoto, Seiko ^a   Chang, Ta Chen ^a   Miyasaka, Kazuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

18FDG PET; Image registration; Nasopharyngeal carcinoma; Oropharyngeal carcinoma; Radiotherapy

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; MAGNETIC RESONANCE IMAGING; TISSUE; TUMORS;

IMAGE FUSION;

RADIOTHERAPY;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ALGORITHM; ARTICLE; AUTOANALYSIS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; IMAGE ENHANCEMENT; IMAGE QUALITY; IMAGING SYSTEM; ISOTOPE LABELING; LYMPH NODE METASTASIS; MALE; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CARCINOMA; PAROTID GLAND; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; STANDARD; TUMOR VOLUME; BRAIN; CARCINOMA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HEAD AND NECK TUMOR; IMAGE PROCESSING; METHODOLOGY; MIDDLE AGED; NASOPHARYNX TUMOR; OROPHARYNX TUMOR; PATHOLOGY; TIME;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BRAIN; CARCINOMA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY, CONFORMAL; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037098863     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02854-7     Document Type: Article

References (32)

1. Nasopharyngeal carcinoma: MRI and CT assessment
2. Staging and follow-up of nasopharyngeal carcinoma: Magnetic resonance imaging versus computerized tomography
3. Skull-base invasion of nasopharyngeal carcinoma: Magnetic resonance imaging findings and therapeutic implications
4. Staging of squamous cell carcinoma of the oral cavity and oropharynx: A comparison of MRI and CT in T- and N-staging
5. PET in lung cancer
6. The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer
7. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis
8. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer
9. A new mold material for customized patient positioning in radiotherapy
10. A fully automatic multimodality image registration algorithm
11. Magnetic resonance imaging (MRI) system for three-dimensional conformal radiotherapy (3D-CRT) and its impact on gross tumor volume (GTV) delineation of central nervous system (CNS) tumors
12. Staging non-small cell lung cancer with whole-body PET
13. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis
14. 2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation
15. Metastatic head and neck cancer: Role and usefulness of FDG PET in locating occult primary tumors
16. FDG PET detection of unknown primary tumors
17. Occult primary tumors of the head and neck: Lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose
18. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site
19. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography
20. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer
21. 18FDG-PET for the assessment of primary head and neck tumors: Clinical, computed tomography, and histopathological correlation in 38 patients
22. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: A potential method to differentiate malignancy from inflammation and normal tissue in the head and neck
23. PET in lung, head and neck cancers
24. Can positron emission tomography improve the quality of care for head-and-neck cancer patients?
25. Staging of the neck in patients with oral cavity squamous cell carcinomas: A prospective comparison of PET, ultrasound, CT and MRI
26. Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience
27. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience
28. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy
29. First experience with I-123-alpha-methyl-tyrosine SPECT in the 3-D radiation treatment planning of brain gliomas
30. Automatic registration of pelvic computed tomography data and magnetic resonance scans including a full circle method for quantitative accuracy evaluation
31. Image registration: An essential part of radiation therapy treatment planning
32. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: The impact of 18FDG-hybrid PET fusion